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Abstract
Background: Hematopoietic development in vertebrate embryos results from the sequential contribution of
two pools of precursors independently generated. While intra-embryonic precursors harbour the features of
hematopoietic stem cells (HSC), precursors formed earlier in the yolk sac (YS) display limited differentiation and
self-renewal potentials. The mechanisms leading to the generation of the precursors in both sites are still largely
unknown, as are the molecular basis underlying their different potential. A possible approach to assess the role
of candidate genes is to transfer or modulate their expression/activity in both sites. We thus designed and
compared transduction protocols to target either native extra-embryonic precursors, or hematopoietic
precursors.
Results: One transduction protocol involves transient modification of gene expression through in situ
electroporation of the prospective blood islands, which allows the evolution of transfected mesodermal cells in
their "normal" environment, upon organ culture. Following in situ electroporation of a GFP reporter construct
into the YS cavity of embryos at post-streak (mesodermal/pre-hematopoietic precursors) or early somite
(hematopoietic precursors) stages, high GFP expression levels as well as a good preservation of cell viability is
observed in YS explants. Moreover, the erythro-myeloid progeny typical of the YS arises from GFP+ mesodermal
cells or hematopoietic precursors, even if the number of targeted precursors is low. The second approach, based
on retroviral transduction allows a very efficient transduction of large precursor numbers, but may only be used
to target 8 dpc YS hematopoietic precursors. Again, transduced cells generate a progeny quantitatively and
qualitatively similar to that of control YS.
Conclusion: We thus provide two protocols whose combination may allow a thorough study of both early and
late events of hematopoietic development in the murine YS. In situ electroporation constitutes the only possible
gene transfer method to transduce mesodermal/pre-hematopoietic precursors and analyze the earliest steps of
hematopoietic development. Both in situ electroporation and retroviral transduction may be used to target early
hematopoietic precursors, but the latter appears more convenient if a large pool of stably transduced cells is
required. We discuss the assets and limitation of both methods, which may be alternatively chosen depending on
scientific constraints.
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In the mouse embryo, hematopoiesis involves the sequen-
tial contribution of two independent waves of precursors
(for review, see [1]). The first precursor generation occurs
in the extra-embryonic compartment, where the yolk sac
(YS) blood islands produce erythro-myeloid-restricted
precursors, from 7.5 days post-coitus (dpc). The second
generation of hematopoietic precursors takes place, from
8.5 to 11.5 dpc, in the region comprising the Aorta and
underlying mesenchyme, which is referred to first as para-
aortic splanchnopleura (P-Sp: 8.5–10 dpc), then as aorta-
gonads-mesonephros region (AGM: 10–11.5 dpc). The P-
Sp/AGM produces hematopoietic precursors endowed
with the multilineage differentiation potential and long
term reconstitution (LTR) capacity that characterise
Hematopoietic Stem Cells (HSC). The P-Sp/AGM pro-
spective territory, the caudal intra-embryonic splanchno-
pleura (Sp: before 8.5 dpc) does not harbour a
hematopoietic potential when cultured in vitro on OP9
stromal cells [2]. Yet, when the early Sp is cultured in toto
for a few days, it now produces hematopoietic precursors,
which harbour a multilineage differentiation potential as
well as LTR capacity [3,4]. As the Sp are explanted before
the establishment of vascular connection with the extra-
embryonic vascular network, which occurs at the 4–5
somite-stage [5,6], this observation shows that the intra-
embryonic site is capable of autonomously generating
HSC. In contrast, the progeny of similarly treated YS lacks
both multipotentiality (they are unable to generate lym-
phoid cells) and LTR activity (they only provide short
term erythro-myeloid reconstitution of irradiated recipi-
ents) [5,6].
The analysis of gene function during the successive steps
leading to the emergence, in the YS, of hematopoietic pre-
cursors with limited differentiation and self-renewal
potentials, by comparison to the events occurring in the
intra-embryonic hemogenic site, constitutes a major issue
for understanding the process leading to HSC generation.
Indeed, the inability of extra-embryonic precursors to pro-
vide a lymphoid progeny and to maintain in the long term
might result from a divergence in the pathways leading
from mesodermal cells to a committed hematopoietic
progeny. This divergence may be (potentially) reflected by
differential gene expression at the time of hematopoietic
induction in both hemogenic sites. We aim to assess
whether genes differentially expressed in the extra- and
intra-embryonic hemogenic sites do indeed play a role in
the distinct potentials displayed by extra- and intra-
embryonic precursors through the forced expression in
the YS of genes only expressed in the intra-embryonic Sp.
Most of the investigations aimed to characterize hemat-
opoietic development pathways in the mouse YS involve
the analysis of either genetically engineered mice strains
or in vitro differentiation potential of modified ES cells,
which may be efficiently transduced by "classical" electro-
poration procedure or retroviral transduction [7]. We here
describe and test an alternative approach that might help
to decipher early steps of developmental hematopoiesis,
by directly targeting YS cells. Moreover, to be able to sep-
arate potential effects on the emergence of native hemat-
opoietic precursors from the blood islands mesoderm
from effects on further differentiation and maintenance of
these precursors, we designed and compared two inde-
pendent protocols. The first, aimed to transiently trans-
duce early blood islands mesodermal/pre-hematopoietic
cells involves in situ electroporation, followed by an organ
culture step prior to hematopoietic development investi-
gations. The second, designed to target YS-hematopoietic
precursors at later stages is based on retroviral transduc-
tion.
Embryo transduction through in situ electroporation [8],
initially used mainly to analyse avian nervous system
development, is now frequently used to study early stages
of mouse ontogeny. This approach allows the introduc-
tion of transgenes into embryonic tissues explants [9] or
into cells of the gastrulating mouse embryo [10-12] to fol-
low cell fate, cell migration and lineage differentiation.
We show here that this technique, which permits a con-
trolled spatio-temporal delivery of transgenes and is com-
patible with the maintenance of transduced cells in their
"natural" environment, is appropriate to analyze YS-
blood islands mesodermal/pre-hematopoietic cells.
Retroviral transduction also constitutes an efficient
approach to transfer cDNA into hematopoietic cells as
well as HSC. Although efficiently used to transduce ES
cells [7], it has yet been rarely used to transduce cells from
early embryos. To our knowledge, it has only been used
once to target 8 dpc YS hematopoietic precursors [13]. In
this study, hematopoietic precursors were shown to
acquire long-term multilineage hematopoietic reconstitu-
tion of irradiated recipients upon stable HoxB4 expres-
sion. However, the extent of efficiency and versatility of
this method on YS cells was not reported. Here, it is
shown that retrovirus-mediated gene transfer is inefficient
to transduce YS mesodermal/pre-hematopoietic precur-
sors, but is a powerful method to genetically modify
hematopoietic precursors from YS at later stages.
Results
A-Gene transfer into early precursors from 7 dpc YS-blood 
islands
I-Determination of suitable stages for mesodermal/pre-
hematopoietic cell targeting
To precisely identify the stage when blood islands are
enriched in immature mesodermal or pre-hematopoietic
cells, we used lmo2 mRNA expression as a marker ofPage 2 of 17
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finger transcriptional co-regulator lmo2 is required for the
generation of hematopoietic precursors of both extra- and
intra-embryonic origin [14,15]. Lmo2 is expressed in the
extra-embryonic mesoderm that gives rise to hematopoi-
etic precursors [16,17], but also by their erythroid prog-
eny. The differentiation of blood islands mesoderm into
mature erythroid cells occurs extremely fast. We thus used
β-H1 mRNA expression, as the earliest marker of differen-
tiating erythroid cells, namely primitive erythroblasts. We
compared the temporal evolution of the expression of
both markers, during early blood islands formation (7.25
to 8 dpc), to select the time window when lmo2 is
expressed and β-H1 not yet/poorly expressed.
Lmo2 transcripts are first detected at the OB stage in the
whole extra-embryonic mesoderm (Fig. 1A) and are sub-
sequently restricted, at the EB stage (Fig. 1B), to a subset
of mesodermal cells, which might correspond to blood
islands precursors. Upon proliferation of these precursors,
lmo2 expression expends to encompass all hematopoietic
derivatives of the blood islands, from the LB to LHF stages
(Fig. 1C, D) [17].
The first β-H1 transcripts are detected at the OB stage in a
limited number of cells located within the lmo2-express-
ing ring (Fig. 1E). The number of cell clusters expressing
β-H1 gradually increases, leading to the formation, at the
LB stage, of a ring which expression overlaps that of lmo2
(Fig. 1F, G). During the following stages (EHF/LHF), this
correlation of lmo2 and β-H1 expression is maintained
(Fig. 1H). The correlation of these two expression patterns
strongly suggest that mesodermal and/or pre-hematopoi-
etic precursors are enriched in the OB to EB YS blood
islands, even if mesodermal cells and native hematopoi-
etic precursors may be still present in the blood islands at
later stages. Targeting mesodermal cells was thus con-
ducted at the OB to EB stages of development (Fig. 1
Lower panel).
II-Developmental constraints imposed on the choice of methodology
At these developmental stages, the determination and fur-
ther proliferation/differentiation of hematopoietic pre-
cursors strictly depend on endoderm/mesoderm
interaction. This implies that a method allowing the
maintenance of tissue structure during transduction will
be required for suitable development of a hematopoietic
progeny from transduced cells. Accordingly, when we nev-
ertheless tested the feasibility of dissociated cells transduc-
tion at the OB-EB stages using lipofection (using
ExGen500) or retroviral transduction (see paragraph B2),
we found that, in both instance, the transduction levels
were naught, and cell viability drastically affected (Data
not shown).
III-Viral-mediated transduction and in situ electroporation of 7dpc YS-
blood islands
Given these constraints, two alternative approaches could
be undertaken to transfer genes into the YS while keeping
its tri-dimensional structure, viral-mediated transduction
[18] and in situ electroporation. Indeed, both methods
have already been used to transfer genes in other embry-
onic tissues and stages.
We first tested the ability of dissected YS to be transduced
in toto by exposure to retroviral supernatant. OB-EB YS-
explants were cultured in medium containing viral parti-
cles for 24 hours (for the method, see B). Explants were
subsequently cultured in fresh medium for two days
before assessing GFP levels and hematopoietic cell pro-
duction. At the outset of the organ culture step, the mor-
phology of transduced YS appeared affected by the
process. Cytometry analysis of these YS explants showed
that only 0.1% of viable cells expressed GFP. These cells
were in addition unable to produce a hematopoietic prog-
eny (data not shown).
We thus investigated in situ electroporation as a second
approach.
1-General scheme of the in situ electroporation protocol
To optimize this method, we used the peGFP-C1 plasmid
(Clontech), which brings on a ubiquitous expression of
the GFP reporter gene driven by the CMV promoter. After
injection of the plasmid into the YS cavity and in situ elec-
troporation, the YS is dissected from the embryo and kept
in organ culture for three days.
The evolution of electroporated YS is systematically com-
pared to non-electroporated control and/or control YS
electroporated without plasmid. The effect of in situ elec-
troporation on the development and viability of YS-
explants is assessed through morphology examination
after the organ culture step, as well as by the detection of
endothelial and erythroid cells differentiation within the
explants. GFP levels allow the monitoring of transduction
efficiency. Finally, the characterization of the hematopoi-
etic progeny of GFP+ sorted cells, obtained upon culture
on OP9 stromal cells, which normally allows the hemat-
opoietic differentiation of mesodermal precursors [19], is
used to typify the targeted precursors.
2-In situ electroporation parameters adapted to YS-mesoderm 
transduction
Previous studies involving in situ electroporation stressed
the importance of several parameters for an efficient DNA
delivery as well a proper preservation of cell viability, and
an accurate tissue targeting [20,21].Page 3 of 17
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Determination of the development stages enriched in immature precursorsFigu e 1
Determination of the development stages enriched in immature precursors. Upper panel: Temporal evolution of 
lmo2 expression from the OB to LHF stages: initially expressed by most extra-embryonic mesodermal cells (A), lmo2 expres-
sion rapidly restricts to a smaller cell number at the EB stage (B). Lmo2 expression subsequently expands with the develop-
ment of blood islands endothelial and hematopoietic cells from LB (C) to LHF (D), and subsequent stages. Middle panel: 
Transcripts of the embryonic globin β-H1 are present in a minute cell number at the OB/EB stages (E, F). During the following 
stages (LB: G to LHF: H, and subsequent stages), β-H1 expressing erythroid cells rapidly expand. The arrows in the upper and 
middle panels point to equivalent zone of the blood islands. Lower panel: The comparative evolution of lmo2 and β-H1 expres-
sions points to embryos at the OB/EB stages as enriched in immature precursors. Scale bar: 100 μm.
BMC Developmental Biology 2007, 7:79 http://www.biomedcentral.com/1471-213X/7/79The electroporation procedure (voltage (V), pulse dura-
tion (ms), number of pulses applied and intervals (ms)
between two pulses) is critical for the maintenance of tis-
sue integrity and effectiveness of construct delivery.
The choice of the electrode type used, the distance
between them and their position regarding the injected
site clearly constitute the most important parameters
influencing cell targeting.
a-Plasmid delivery
Targeting the YS-mesodermal/pre-hematopoietic precur-
sors, while avoiding endoderm transduction, requires the
injection of the construct into the YS cavity, since the mes-
oderm layer is facing this cavity while endoderm is
exposed to the external environment. The embryos are
freed from the decidua and Reichert's membrane (Fig. 2A,
B) to allow injection. A capillary, back-filled with 1 μg/μl
peGFP-C1 plasmid DNA solution is inserted into the YS
cavity from the node region and through the amnios. Fast
Green (0.01%) is added to the solution to visualise con-
struct delivery. This injection mode, designed to limit
plasmid release from the YS cavity, leads to the collapse of
the amnion towards the ectoplacental cavity. Upon
mouth driven-release of the plasmid, the amnion returns
to its former position and an accurate injection can thus
be visualized by the fast green filling of the YS cavity (Fig.
2C, D).
b-Electrode positioning and electroporation parameters
Electroporation allows gene delivery into the specified cell
subset provided that the path of the negatively charged
DNA towards the positive electrode (anode) is correctly
adjusted. Careful examination of wholemount β H1 and
lmo2 in situ hybridization patterns allocated the blood
islands to the median third of the distance extending from
the floor to the roof of the YS-cavity. Following injection,
the two electrodes (gold genetrodes 512 from BTX) are
thus positioned at each side of the YS (Fig. 2E), parallel to
the presumptive blood islands ring.
We used a square-wave pulse generator (ECM830, BTX) to
deliver the construct at a low voltage, thus preserving tis-
sue integrity. The best results (efficient electroporation,
preservation of explants morphology and recovery of a
normal hematopoietic progeny from transfected precur-
sors, see below) are obtained with five 50 ms pulses of 30
V at 500 ms intervals, with a 4 mm distance between the
electrodes (Fig. 3). In theory, with such settings, a maxi-
mum 40–50% of the blood islands cells might take up the
plasmid. In order to increase the targeted area, pulses were
applied twice, with an inverted field, using the same
parameter set-up. Unfortunately, the gain in the number
of transduced cells was annihilated by a decrease in cell
viability (Data not shown).
3-Development of electroporated YS-explants during organ culture
When placed in organ culture, YS-explants, both non-elec-
troporated control and electroporated (with or without
plasmid), rapidly form a bubble-like (Fig. 4A) structure
that mimics YS development. It contains cell clusters sim-
ilar to those observed in control blood islands (Fig. 4B).
Moreover, differentiation along the erythroid (Fig. 4A, B)
and endothelial (Fig. 4C, D) lineages normally occurs.
After 3 days in organ culture, the explants have progres-
sively organized into a bipolar structure with most meso-
derm slightly adhering to the plastic dish, while the
endoderm is exposed to the external environment, as
shown by the expression of α-foeto-protein (AFP) tran-
scripts, as a visceral endoderm marker [22] (Fig. 4E–H).
Within the mesodermal layer, β-H1-expressing erythroid
cells are mostly located at the adhering site (Fig. 4I, J see
also Fig. 4A, L), while lmo2-expressing cells are more
largely distributed in the YS-explants (Fig. 4K).
GFP can be visualized in electroporated YS after on aver-
age three hours and is still detected after the 3 days of
organ culture. In YS explants, GFP+ cells are mostly located
within the blood islands-like clusters and the adhering
site (Fig. 4L–O), which provides a first indication that the
prospective blood islands has been accurately targeted.
4-Hematopoietic recovery from electroporated YS-explants kept 3 
days in organ culture
a-Characterization of the hematopoietic progeny of transduced cells
We next analysed by flow cytometry the presence of trans-
duced hematopoietic cells in YS-explants immediately
after the three days in organ culture (thereafter referred to
as OrgD3-YS). The percentage of GFP positive cells repre-
sents on average 0,5–1% of the whole OrgD3-YS popula-
tion (corresponding to 50–100 cells), a percentage
classically obtained using unilateral electroporation pro-
cedure in mouse embryonic tissues [9,23]. The presence of
both c-kit and CD45 positive cells within the GFP+ subset
(Fig. 5A) confirms that mesodermal/pre-hematopoietic
cells, capable to give rise to a hematopoietic progeny, were
successfully transduced.
In order to assess whether the targeted mesodermal/pre-
hematopoietic precursors keep a normal differentiation
pathway, we next analysed the differentiation potential of
sorted GFP+ cells after a 5 days culture on OP9 stromal
cells. These cells gave rise to the typical YS progeny,
namely Mac-1+/CD45+ macrophages and Ter119+ eryth-
roid cells, and few c-kit+/CD45+ precursors (Fig. 5B), indi-
cating that the GFP plasmid was indeed transferred to
mesodermal/pre-hematopoietic precursors. Interestingly,
GFP is not expressed by their hematopoietic progeny
(data not shown), reflecting the non-integrated status,
and hence the transient expression, of the transgene.Page 5 of 17
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Plasmid injection protocolFigure 2
Plasmid injection protocol. Abbreviations: am: amnion; EPC: Ectoplacental cone; YSC: YS cavity OB-EB stage embryos are 
dissected from the decidua (A). The Reichert membrane is removed, while the EPC is kept in place (B). The plasmid solution is 
injected into the YSC, from the node region through the amnion (C). Plasmid filling of the YSC is visualised with fast green (D). 
Prior to pulse application, the electrodes are positioned parallel to the prospective blood islands ring (E). After electropora-
tion, the YS is dissected from the embryo and placed in organ culture (D). Scale bar: 100 μm.
In situ electroporation parametersFigur  3
In situ electroporation parameters. Left: Scheme of a square wave pulse delivered during in situ electroporation. Right: 
Optimal parameters used for YS in situ electroporation at the OB-EB stages.
`
ECM830 + Gold genetrodes (BTX) 
a- Pulse intensity (Volt) 30 
b- Pulse duration (ms) 50 
c- Interval between pulses (ms) 500 
d- Number of pulses 5 
e- Distance between the electrodes (mm) 4 
f- Plasmid concentration (Pg/Pl) 1Page 6 of 17
(page number not for citation purposes)
BMC Developmental Biology 2007, 7:79 http://www.biomedcentral.com/1471-213X/7/79Cytological analysis of electroporated OrgD3 YS-explantsFigure 4
Cytological analysis of electroporated OrgD3 YS-explants. Abbreviations: AFP: α-foeto-protein; Control non-electro-
porated YS-explants (A), maintained in organ culture, organise into a "bubble-like" structure that contains a compacted part, at 
the site adhering to the culture dish (asterisk). Erythroid cells (arrow), differentiated from explanted YS mesoderm, are located 
close to this adhering site (A). The "bubble-like" part harbours clusters similar to YS-blood islands (B: Enlargement of the 
square in A), which also contains erythroid cells (arrow). CD31+ cells are present in the both in the "bubble-like" structure and 
adhering site (asterisk) (C). Whereas in the adhering site, the nature of labelled cells (arrows) is unclear, CD31+ endothelial 
cells (D) are clearly present cells in the bubble. In electroporated YS explants, both without (E, F) or with (G, H) plasmid, the 
endoderm, revealed by AFP wholemount in situ hybridization, remains external, but does not cover the whole mesoderm, as 
shown on the sections of wholemount embryos (F, H) made along the axis shown in E, G. β-H1+ erythroid cells (I, control YS 
and J, electroporated YS) are mostly located at the adhering site (asterisk), while lmo2-expressing cells (K, control YS) are dis-
tributed either in the adhering site (asterisk) or in close contact with the endoderm (arrow). At the end of the organ culture 
step, both the blood islands-like clusters and the adhering sites (L, N) display GFP+ cells (M, O: same explants as L, N), often in 
area containing erythroid cells (arrows). Scale bars: 100 μm, except D: 20 μm.Page 7 of 17
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The frequency of hematopoietic precursors present in con-
trol OrgD3-YS, as well as in OrgD3-YS electroporated
without plasmid, was quantified by culture in limiting
dilution on OP9 stromal cells for 5 days. In control
OrgD3-YS, an average 1 out of 480 cells gives rise to a
hematopoietic progeny, which corresponds to about 10–
11 precursors per YS (Fig. 5C, Table 1). A similar fre-
quency (1 hematopoietic precursor out of 453 cells) is
obtained from OrgD3-YS electroporated without plasmid
(Table 1), indicating that our electroporation protocol
does not affect the recovery/viability of hematopoietic
precursors.
c-Efficiency of the gene transfer into mesodermal/pre-hematopoietic 
precursors
We next quantified the recovery of hematopoietic precur-
sors derived from transduced mesodermal cells. As stated
above, our unilateral electroporation procedure only
delivers the construct to at the best 40–50% of the blood
islands, corresponding to 5–6 precursors per YS.
Sorted GFP+ cells were distributed at 10 or 30 cells per
wells on OP9 stromal cells and scored for the presence of
a hematopoietic progeny five days later. In five independ-
ent experiments, on average 1/150 GFP+ cell displayed a
hematopoietic potential (Table 1). This value corresponds
to a 3-fold enrichment in hematopoietic precursors com-
pared to control OrgD3-YS. This enrichment indicates the
presumptive blood islands were accurately targeted dur-
ing the in situ electroporation step. However, the absolute
number of GFP+ hematopoietic precursors (0.56 ± 0.18
obtained per 0.5 YS-equivalent) remains low (Table 1),
even though a hematopoietic progeny is systematically
obtained from transduced mesodermal/pre-hematopoi-
etic precursors.
B-Transduction of 8 dpc YS-hematopoietic precursors
I-In situ electroporation
We investigated whether in situ electroporation is also effi-
cient to target hematopoietic precursors at later develop-
ment stages (From EHF stage to the 5-S stage). The same
settings were applied to transfer the plasmid to the blood
islands. Electroporated YS were kept in organ culture for
one day (instead of the 3 days in organ culture for 7 dpc
YS, required for the differentiation of mesodermal/pre-
hematopoietic precursors) to allow for GFP expression
prior to sorting. Flow cytometry analyses, performed
immediately after the organ culture step, showed that
GFP-expressing cells again represented 0.5–1% of the
whole population. Upon sorting and culture on OP9 stro-
mal cells for 5 days, these cells produced a hematopoietic
progeny comparable to that obtained from whole control
(non-electroporated) YS. These data indicate that in situ
electroporation may be used to transduce hematopoietic
precursors at 8 dpc.
II-Retroviral transduction
However, at this stage, the blood islands have developed
into vessels filled with hematopoietic cells, so that the
hematopoietic precursors are diluted amongst erythroid
cells (Figure 1D, H). Thus electroporation appears less
convenient at this stage while a method ensuring a high
efficiency of transduction (with respect to the whole pop-
ulation) would be more adapted. In addition, at 8 dpc,
contrary to 7 dpc, blood islands precursors can be directly
obtained from dissociated YS. We took advantage of these
features to examine whether retroviral transduction
would be adapted to efficiently transfer genes into hemat-
opoietic precursors from 8 dpc YS.
1-General scheme of the protocol
Transduction using ecotropic retrovirus has previously
been used to transfer HoxB4 into 8 day YS hematopoietic
precursors [13]. However, neither quantitative data nor
optimization of the various infection parameters was pro-
vided.
As a first step, the following protocol was designed to tar-
get gene to hematopoietic precursors from 8 dpc (0–4
somite stages) YS. In this study, transduction of hemat-
opoietic precursors was obtained using a MSCV-based ret-
roviral vector called MPI. This retroviral vector harbours,
as a FACS-selectable reporter, the eGFP cDNA down-
stream a IRES element [24].
We first compared the transduction efficiency attained
using freshly isolated YS or YS explants dissociated after
one day in organ culture (thereafter referred to as OrgD1-
YS). In both conditions, we systematically analysed: 1-
GFP level at day 1 post-infection (i.e. 24 hours after expo-
sure to the viral supernatant), 2- the persistence of GFP
expression in YS-transduced cells during in vitro hemat-
opoietic differentiation, 3- the viability and phenotype of
the hematopoietic progeny of sorted GFP+ cells, 4- the
number and the type of hematopoietic cells produced
upon in vitro culture on OP9 stromal cells or in methylcel-
lulose assay. In both instances (8 dpc YS freshly explanted
or maintained in organ culture for one day), all these
analyses were performed after GFP+ cell sorting at day 1
post-infection.
2-Retroviral transduction of 8 dpc YS on freshly isolated cells or after 
organ culture
In our first tests, we used the MPI retroviral vector to trans-
duce 8 dpc YS directly upon dissection. After dissociation,
YS cells are seeded in a 48-well plate in 1 ml medium sup-
plemented with cytokines and 4 μg polybrene (see Mate-
rials and Methods). After addition of the retroviralPage 8 of 17
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A: Hematopoietic progeny obtained from OrgD3 electroporated YSFigure 5
A: Hematopoietic progeny obtained from OrgD3 electroporated YS. GFP+ cells display hematopoietic markers indicating that 
pre-hematopoietic mesodermal cells were targeted. B: GFP+ cells sorted from electroporated OrgD3-YS give rise, after a 5 day 
culture on OP9 stroma, to the hematopoietic progeny typical of the YS, i.e. few precursors (left panel), myeloid (middle panel) 
and erythroid (right panel) cells. C: Frequency of hematopoietic precursors within OrgD3 control YS (see also Table 1) 
obtained by limiting dilution assay.
BMC Developmental Biology 2007, 7:79 http://www.biomedcentral.com/1471-213X/7/79supernatant (MOI = 1), the culture is maintained at 37°C,
5% CO2 for 12 hours and re-plated in fresh medium and
either seeded on OP9 stromal cells or analysed for clono-
genic potential in methylcellulose assay. In these condi-
tions, the initial efficiency of transduction is reproducible
and quantitatively high (60–70% GFP+ cells). However,
the GFP+ population rapidly decreases in culture to com-
pletely vanish after 4–5 days (Fig. 6A). The 8 dpc YS is
enriched in terminally differentiated hematopoietic cells
and immature erythro-myeloid precursors only appear at
the 2–5 somite-stage [25,26]. Accordingly, we suspect that
the rapid exhaustion of the GFP+ population during the 4
days culture arises as a consequence of the relative matu-
rity of the transduced cells, which therefore rapidly com-
plete differentiation and disappear.
A mean to obtain a larger number of targeted hematopoi-
etic precursors and still avoid cross-contamination by
intra-embryonic-derived hematopoietic precursors, is to
place the YS, dissected before the 4 somite-stage for one
day in organ culture (OrgD1), as previously described
[3,4]. Thus, dissociated OrgD1-YS cells were exposed to
the retroviral supernatant with the same MOI and cul-
tured as described above. Under these conditions, trans-
duction efficiency is also highly reproducible, but lower
(25–30%) than in the former conditions. However, in
sharp contrast with the former conditions, the absolute
number of GFP+ cells increases between 4 and 8 days post-
infection (Fig. 6A). Moreover, the percentage of GFP+ cells
also increases during the culture to reach a maximum
(50–60%) at day 4 post-infection (Fig. 6B). Since about
15–20% of GFP-negative cells sorted at day 1 post-infec-
tion are shown to acquire GFP expression over the follow-
ing days in culture (Fig. 6B), the increase in GFP+
population between day 1 and day 4 post-infection may
result, at least in part, from de novo GFP expression. Inter-
estingly, when observed in semi-solid culture, the colo-
nies appear as entirely composed of strongly GFP positive
cells, which indicates that the whole progeny of trans-
duced hematopoietic precursors keeps the expression of
the transgene (Fig. 6C). The threefold increase in the
number of monopotent as well as multipotent clonogenic
precursors among the GFP+ cells at day 4 compared to that
obtained from 8 dpc YS transduced immediately after
explantation (Fig. 6D), confirms that inclusion of a organ
culture step leads to a transduction of a higher number of
hematopoietic precursors. The persistence of GFP express-
ing cells, when transduced cells derive from OrgD1-YS,
thus reflects that the organ culture step indeed improves
the targeting of immature precursors.
We therefore focused on the protocol including the organ
culture step for further analyses of the hematopoietic phe-
notype and differentiation potential of transduced cells.
3-Hematopoietic development from YS transduced cells
Flow cytometry analysis of the percentage of 7AAD
labelled cells shows no difference in cell viability between
infected or non infected YS-cells after one or four days in
culture on OP9 stromal cells (Data not shown). In our
conditions, the proliferation rate is perfectly equal
between transduced and non-transduced cells (Data not
shown).
The phenotype of hematopoietic cells recovered from
OrgD1-YS at 24 hours post-infection is similar to that of
control OrgD1-YS (data not shown). Moreover, the vari-
ous hematopoietic subsets, both myeloid (CD45+) and
erythroid (c-kit+/Ter 119+) are similarly distributed within
the GFP+ and GFP- populations (Fig. 7A). The fact that the
retrovirus-mediated transduction protocol does not dis-
turb hematopoietic differentiation from OrgD1-YS is also
evidenced upon phenotype analyses performed at day 4
after culture on OP9 stromal cells, since the relative per-
centage of erythroid and myeloid cells is not modified in
transduced cells compared to normal YS (Fig. 7B).
We coupled the phenotype analyses to in vitro clonogenic
assay to verify that the differentiation potential of trans-
duced precursors was not modified by the whole proce-
dure. As shown in Fig. 7C, in three independent
experiments, the clonogenic potential obtained from
sorted GFP+ does not significantly differ from that
obtained from similar number of OrgD1 control (nor-
mal) YS, both at days 1 and 4 post-infection. The clono-
genic potential thus correlates with the phenotype
analyses performed at the same time points (Fig. 7A,B).
In conclusion, there is no phenotypic as well as differenti-
ation potential bias between GFP+ and GFP- cells recov-
ered from Org-D1 transduced YS. Moreover, our results
(to be published elsewhere) obtained following retroviral
transduction of a candidate gene into Org-D1 YS indicates
that insertion of a 2 kb cDNA into the MPI vector: 1- does
reduce neither the GFP level nor the percentage of trans-
duced cells, 2- allows the identification of the exogenous
protein through Western Blot. This procedure is thus
adapted to analyse the effect of candidate gene on YS-
hematopoietic cells development.
Discussion
The analysis of the first steps of hematopoietic develop-
ment historically performed though the study of the yolk
sac, is somehow limited by the poor level of available pre-
cursors, as well as their extremely fast differentiation.
Great progress in the understanding of the development
of primitive hematopoiesis was achieved, owing to the ES
model, once the similarity of developmental sequence
with that which occurs in vivo was firmly established [27].
The availability of large number of ES cells, amenable toPage 10 of 17
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the mechanisms involved (e.g. through invalidated ES
cells rescue experiments). Unfortunately, the gathered
information cannot be easily placed back to back to simi-
lar experiments conducted in the "normal" YS develop-
mental context.
Here we provide two gene transfer protocols, whose com-
bination may allow a thorough study of both early and
late events of hematopoietic development in the YS.
Thanks to two markers which make it possible to discrim-
inate between mesodermal/pre-hematopoietic (lmo2+/β-
H1-) [17] and their erythroid progeny (lmo2+/β-H1+), we
precisely determined the stage when the YS blood islands
are enriched in immature precursors. This expression
analysis also allowed to precisely locate the prospective
blood islands in intact 7 dpc YS. We next used this delin-
eation to perform in situ electroporation, which keeps
intact the mesoderm-endoderm interactions shown to be
crucial for proper hematopoietic development at these
stages [28,29]. This approach was proven here to be effec-
tive to target mesodermal/pre-hematopoietic precursors
and to be completely compatible with a normal viability
and hematopoieisis of the transfected mesodermal/pre-
hematopoietic precursors upon organ culture and subse-
quent in vitro culture on OP9 stromal cells. Thus, our work
provides for the first time a detailed procedure allowing
the analysis of the very early steps (determination) of
primitive hematopoiesis. However, although our protocol
ensures a significant enrichment of hematopoietic cells in
the transfected population (three folds), the overall yield
remains low (about 1 transfected mesodermal/pre-hemat-
opoietic precursors per YS) for two reasons: 1- the intrin-
sic paucity of this precursor type in the 7.5 YS (about 10,
after the 3 days in organ culture); 2- the relatively low,
albeit usual in related experiments [9,23], level of gene
transfer through in situ electroporation. Yet, this limita-
tion does not disqualify the procedure since qualitative
analyses following transfer of candidate genes can be per-
formed.
A complementary protocol was then provided to transfer
gene in « late » (8 dpc) YS which contains numerous deter-
mined cells. At this stage, hematopoietic precursors are
much less precisely localized than their mesodermal
ancestors, but rather dispersed and diluted among an
abundant differentiated (essentially erythroid) progeny.
Moreover, the differentiation of these cells is not anymore
dependent upon interaction with endodermal cells. We
thus reasoned that a « blind » (i.e. non selective) but effi-
cient method would be the most adapted and therefore
performed ecotropic retrovirus-mediated gene transfer
onto isolated YS cells. A similar strategy has been previ-
ously used to express HoxB4 into YS cells at about the
same stage [13]. However, neither indication about the
efficiency of the method, nor quantitative data were pro-
vided. This is of particular importance given that the
nature of the transduced gene in this study may confer
such a high competitive growth/survival advantage that
even a weak efficiency of transduction may have been suf-
ficient. We show here that even for a «neutral» gene
(eGFP), the transfer through ecotropic retrovirus in 8 dpc
YS hematopoietic precursors is very potent, therefore
overcoming the problem of precursor dilution. Indeed,
over 60% of the YS cells were transduced using a MOI as
low as 1. In fact, YS cells appear highly susceptible to ret-
roviral transduction as a very short contact (4–6 hours)
with the viral supernatant is sufficient to produce a maxi-
mal transduction which therefore minimizes the potential
side effects of concentrated viral supernatant or of poly-
brene, and allows a precise temporal targeting of the
beginning of gene transfer. Moreover, we show that
including a 24 h organ culture step before exposure to the
viral supernatant markedly improves the targeting of
immature precursors. This may result from an increased
precursor frequency, as evidenced by the higher recovery
of clonogenic precursors obtained when GFP+ cells are
sorted from OrgD1-YS. As a consequence, even though
the protocol that includes an organ culture step leads to a
lower percentage of transduced cells, GFP+ cells steadily
increase from day 4 post-infection, while they rapidly van-
ish when recovered from freshly transduced YS. Further
analysis of the hematopoietic progeny of transduced cells
is therefore easier under these conditions. Confirming the
high permissiveness of YS cells to retroviral transduction,
we found that a MPI vector carrying a 2 kb cDNA is almost
as efficient as the empty one at transducing OrgD1-YS
hematopoietic precursors.
Table 1: In situelectroporation efficiently delivers the construct to the blood islands
Frequency of recovered 
hematopoietic precursors
Number of recovered 
hematopoietic precursors per YS
Number of 
experiments
Whole OrgD3-YS 1/475 10–11 4
Whole OrgD3-YS electroporated without plasmid 1/453 10 3
OrgD3-YS GFP+cells 1/150 (± 57.62) 0.56 ± 0.18 per 0.5 YS (targeted area) 5
Hematopoietic precursor frequency within whole control YS (electroporated without construct) and GFP+ cells sorted from electroporated YS-explants were determined 
through limiting dilution assay.Page 11 of 17
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vival and differentiation potentials of retrovirally trans-
duced YS cells appear undistinguishable from that of non-
transduced cells. Thus, retroviral transduction appears as
a very convenient way to genetically modify hematopoi-
etic precursors from 8 dpc YS.
Two potential problems, however, limit the use of retrovi-
ral transduction:
1- in our conditions, 7 dpc YS cells (i.e. containing meso-
dermal/pre-hematopoietic precursors cells), which are
amenable to gene transfer by in situ electroporation,
appear almost totally refractory to retroviral transduction.
The reason for this pitfall is unknown, but we suspect that,
at this early development stage, mesodermal cells have
not yet reached some degree of commitment/differentia-
tion that allows retroviral transduction. Indeed, 7 dpc YS
mesodermal/pre-hematopoietic precursors become effi-
ciently transduced after a two days of organ culture, which
essentially recapitulates their in vivo progression toward
committed precursors.
2- Retroviral vector are stably integrated, and therefore
transduced cells are indelibly genetically modified. This is
confirmed by the expression of GFP after at least two
weeks of culture (latest time point analysed) in retrovi-
rally transduced cells from late YS. In contrast while GFP
is still detectable in electroporated cells from 7 dpc YS
after 4 days, it completely vanished a few days later. In
view of this limitation, we show that our in situ electropo-
ration protocol transduce hematopoietic precursors from
A: Compared evolution of cell production obtained from GFP+ cell sorted from 8 dpc YS infected upon explantation (between bracket: numb r of cells re overed at day 8), or afte  one day in organ cultureFigure 6
A: Compared evolution of cell production obtained from GFP+ cell sorted from 8 dpc YS infected upon explantation (between 
bracket: number of cells recovered at day 8), or after one day in organ culture. B: Evolution of GFP expression in the whole 
population or in GFP- cells sorted from transduced 8 dpc OrgD1-YS after culture on OP9 stromal cells. A steady state GFP 
expression is attained at day 4 post-infection. Moreover, GFP expression is acquired, during culture, by a subset of GFP- sorted 
cells. C: GFP expression in transduced OrgD1-YS cells (top panel left) persists in sorted GFP+ cells cultured on OP9 stromal 
cells (top panel right). The colonies generated by transduced cells also remain entirely GFP+ (bottom panel).Page 12 of 17
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sient expression is needed. Note that a 4 days expression
may appear somewhat long with respect to the accelerated
dynamic of embryonic events, especially in the case of
early hematopoiesis. However, given the intense prolifer-
ation of early YS cells, we suspect that the plasmid deliv-
ered by in situ electroporation is in fact rapidly diluted so
that the expression of labile proteins will be expected to
be more really « transient » than that of GFP, whose half
life exceeds 24 hours.
Conclusion
In summary (Table 2), we provide and detail here two
complementary methods to transfer genes in YS cells, at
the earliest stages of hematopoietic development (7–8
dpc). We studied the influence of several parameters and
hence determined the most convenient for either early
(mesodermal/pre-hematopoietic) and late (hematopoi-
etic) precursor transduction. These two methods can be
used to either enforce (as exemplified here) or knock-
down (through vectorized siRNA) the expression of
potentially important genes. They are thus likely to
Hematopoietic development from transduced cellsFigure 7
Hematopoietic development from transduced cells. A: Comparison of the clonogenic potential of GFP+ cells sorted at 
day 4 post-infection from YS infected upon explantation or after one day in organ culture. B: Phenotype analyses of OrgD1-YS 
infected cells cultured for 1 day on OP9 stromal cells, show that erythroid (Ter199+) and myeloid (CD45+) cells are identically 
distributed within GFP+ and GFP- subsets. C: At day 4 post infection, the distribution of erythroid (Ter199+) and myeloid 
(CD45+) cells within the GFP+ population is similar to that obtained from normal YS (never exposed to viral supernatant). D: 
Clonogenic assays, performed at day 1 (left panel) and 4 (right panel) post-infection, indicate that the transduction procedure 
does not modify the type and numbers of precursors recovered.Page 13 of 17
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primitive hematopoiesis and to understand the molecular
basis underlying its limited potency, when compared to
true HSC from the AGM or adult BM.
Methods
1-Mice and isolation of embryo
All animal experiments were conducted in compliance
with French and European regulations. Balb/c or C57BL/
6 males are crossed with females to generate embryos and
the morning of the vaginal plug observation is considered
as 0.5 dpc. Pregnant females are sacrificed by cervical dis-
location. Embryos at 8 dpc are staged by somite counting.
Presomitic embryos are staged according to the develop-
ment of the allantois bud: OB (No Bud), EB (Early Bud)
and LB (Late Bud) [30].
2-Isolation and organ culture of 7 and 8 dpc Yolk Sacs
Embryos from OB to EB stages, used for in situ electropo-
ration, are collected in Hanks balanced salt solution
(HBSS: Invitrogen), and after removal of the Reichert
membrane (the ectoplacental cone being preserved), they
are injected with the plasmid solution as described below.
After injection and pulse application, the extra-embryonic
compartment is removed with ultra-fine forceps and
maintained in organ culture as described below. From 8
dpc, the YS used for retroviral infection, are directly
explanted from the embryos.
YS explants are transferred into 6-well plates (TPP) con-
taining "Complemented OptiMEM medium", i.e. Opti-
MEM with Glutamax (Invitrogen), 10% Fetal Calf Serum
(Hyclone), 1% Penicillin-steptomycin (Invitrogen) and
0.1% β-mercaptoethanol (Invitrogen), and are kept in cul-
ture at 37°C, 5% CO2 for 1 (8 dpc) or 3 (OB and EB
stages) days, before analyse (OB and EB stages) or retrovi-
ral infection (8 dpc). Prior to further processing, YS-
explants are dissociated by gentle pipeting and filtered to
obtain a single cell suspension.
3-In situ Electoporation
For in situ electroporation, we use the peGFP-C1 vector
(Clontech), in which the cytomegalovirus (CMV) pro-
moter drives the expression of the GFP reporter protein.
To visualise plasmid solution delivery, 0.01% Fast Green
is added to 1 μg/μl peGFP-C1 plasmid DNA. Borosilicate
standard wall (1.0 mm O.D./0.58 mm I.D.) glass capillar-
ies (Harvard Apparatus) are pulled and filled with DNA/
Fast Green solution for injection.
After dissection, the plasmid solution is injected in the YS
cavity as described in Fig. 2, and embryos are placed in a
Petri dish, in HBSS. To accurately target the presumptive
blood islands, OB-EB embryos are oriented so that the
caudal half part of the visceral YS is facing the anode. The
two gold genetrodes (BTX Instrument Division Ref 512)
are positioned parallel to the presumptive blood islands,
and pulses are applied using a square-wave pulse genera-
tor (Electro Square Porator ECM 830, BTX Instrument
Division; San Diego, CA, USA).
4-Retroviral infection of 8 dpc YS
Production of ecotropic retroviral supernatants
We used for retroviral transduction a MSCV-based retrovi-
ral vector, called MPI [24]. HEK 293T cells (4 × 106 cells;
30–40% confluence) are seeded in DMEM supplemented
with 10% FCS and 1% Penicillin-steptomycin (Invitro-
gen), in 150 mm culture dishes. The following day, the
MPI expression vector (6.4 μg) is co-transfected with 3.2
μg phCMV-intron GagPol and 3.2 μg FB-MO-SALF [31]
helper plasmids, encoding the MLV gag-pol and ecotropic
env proteins, respectively, using Fugene 6 (Roche), as
transfection reagent, to produce retroviral particles. Viral
supernatants are collected twice a day, from 24 h to 72 h
post-transfection, filtered (0.45 μm) and concentrated on
Centrifugal Filter Devices (Centricon®Plus-20 from
MICON Bioseparation). Concentrated supernatants are
distributed into 30 μl aliquots, kept frozen at -80°C. Titra-
tion is performed by transducing mouse 3T3 fibroblasts
(plated at 105 cells per well in 6-wells plates) in exponen-
tial growth phase with 5 μl concentrated supernatant in
the presence of 4 μg/ml polybrene. Cells are analysed for
GFP expression 4 days post exposition to the viral super-
natant, by flow cytometry using a Facscan (Becton Dickin-
son). Typically, the titre of concentrated supernatants is 7
× 106-107 viral particles per ml.
Retroviral transduction conditions
Ten dissociated YS explants (about 105 cells) are seeded in
48 well-plates containing 1 ml "Complemented Opti-
MEM medium", further supplemented with Flt3-ligand
(20 ng/ml), Stem Cell Factor (100 ng/ml), EPO (103 U/
ml) and 4 μg polybrene. Viral supernatant is added to
obtain one retroviral particle per cell (MOI = 1) during 12
hours. After infection, transduced cells are transferred on
OP9 stromal cells and cultured as described below. Inter-
estingly, a 25–30% transduction efficiency is achieved on
OrgD1-YS, either with a 24 hours or a shorter (4 or 6
hours) exposure to the retroviral supernatant.
5-Expression analyses
In situ hybridization
YS explants, fixed in 4% paraformaldehyde in PBS over-
night at 4°C and rinsed with PBS, are hybridized with
riboprobes at 65°C, as previously described [32]. Digoxi-
genin (DIG)-labelled antisense RNA probes are obtained
from PCR fragments subcloned into expression vectors
(βH1, provided by I. Max-Audit: 250 bp subcloned into
pCR™; Lmo-2 constructed by V. Lemarchandel: 450 bpPage 14 of 17
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vided by L. Robb: 845 bp subcloned into pBSKII) and syn-
thesized using the DIG RNA Labelling Kit (Roche
Diagnostics, Indianapolis, IN). To obtain cryostat sections
of hybridized samples, YS explants are fixed (4% parafor-
maldehyde, 4% sucrose, 0.12 M CaCl2, 0.2 M Na2HPO4,
0.2 M NaH2PO4, H2O), embedded in 0.12 M phosphate
buffer, 7.5% gelatin, 15% saccharose and frozen in liquid
nitrogen. Embedded embryos are sectioned at 10–15 μm
and transferred to Superfrost slides.
Immuno-histochemistry
Cryostat sections of YS explants, prepared as described
above, are incubated first with 0.3% H2O2 to block endog-
enous peroxydase activity, then in PBS, 10% fetal calf
serum (2 hours at room temperature) to prevent non spe-
cific antibody binding. Samples are incubated with puri-
fied Rat anti-Mouse CD31 (clone MEC13.3, Pharmingen)
overnight at 4°C, followed by incubation with bioti-
nylated-Goat anti-Rat (DAKO), as secondary antibody for
1 hour at room temperature and Streptavidine-horserad-
ish peroxydase complex (VECTOR) for 30 Min. at 37°.
Peroxydase activity is revealed by exposure to its diami-
nobenzidine substrate. Sections are mounted in Glycergel
(DAKO) and photographed using DIC optics.
6-Microscopy and photography
Samples are observed either on a Fluorescence-equipped
Olympus SZX12 stereomicroscope (wholemount in situ
hybridized or electroporated YS) or on a Zeiss Axioplan
microscope (YS-explants sections). Images are acquired
respectively with the DP50 Olympus digital camera (Anal-
ysis software) or Zeiss AxioCam MRc (Axiovision 4.3 soft-
ware). Images are further processed with the Adobe
Photoshop CS software.
7-Analysis of hematopoietic cell production
Culture on OP9 stromal layer
Cells are seeded on OP9 stromal cells (from S.-I.
Nishikawa and T. Nakano, Riken Center for Developmen-
tal Biology, Kobe, Japan), in "Complemented OptiMEM
medium", further supplemented with Flt3-ligand, Stem
Cell Factor and EPO, and cultured as described in [32]. At
various culture time points, cells are analysed by flow
cytometry or submitted to clonogenic assays.
Clonogenic assay
Cells recovered after 1 or 4 days from the culture on OP9
stroma, are assayed for the presence of colony-forming
units, by seeding 3000 cells per 30 mm culture dish, in
triplicate, in 1 ml methylcellulose medium (M3234; Stem
Cell Technologies, Vancouver, BC, Canada) supple-
mented with cytokines (50 ng/ml Stem Cell Factor, 10 ng/
ml Il-3, 10 ng/ml Il-6, 3 U/ml EPO and 10 ng/ml TPO).
After 3 to 7 days at 37°C, colonies are scored based on
their morphology on an inverted microscope.
Flow Cytometry Analyses and cell sorting
Cells are analyzed on a FACS Sort (Becton-Dickinson) as
previously described [32], and FACS data are analyzed
with CellQuestPro software (Becton-Dickinson).
The following antibodies (all from Pharmingen) are used
to reveal the presence of lineage-specific surface markers:
CD45 (Clone 30-F11), CD31 (Clone MEC 13.3) and Mac-
1 (Clone M1/70) for myeloid cells, Ter119 (Clone Ly-76)
Table 2: Assets and limitation of in situ electroporation and retroviral transduction to target YS blood islands precursors
In situ electroporation Retroviral transduction




- Layer specific delivery
- Spatial control of delivery
- Reduced number of 
precursors available for 
transduction
- Causes extensive cell death
- Refractory to transduction ?
Application Only possible method Unsuitable at this development stage
From 7.5–8 dpc: Hematopoietic 
precursors
- Transient 
- Layer specific delivery
- Spatial control of delivery
- Only a fraction of the YS blood 
islands is targeted
- Easy
- All hematopoietic precursors 
may be transduced
- Does not allow layer specific 
targeting
Application -Transient transgene delivery - Sustained expression of the transgene
- Possible layer specific delivery. - Possible delivery of ShRNA
- Possible delivery of SiRNA or proteins
Hematopoietic precursor frequency within whole control YS (electroporated without construct) and GFP+ cells sorted from electroporated YS-explants were determined 
through limiting dilution assay.Page 15 of 17
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Diva cell sorter (Becton-Dickinson).
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